Elisabetta Bianchini, PhD, National Research Council, Italy
Christopher C. Mayer, PhD, AIT Austrian Institute of Technology, Austria
Artery Research is calling for submissions to our Collection on translational science in the field of vascular ageing assessment, one of the key focuses of the COST Action VascAgeNet.
For further information, please, read About the collection section below.
Image credit: vascagenet.eu
Elisabetta Bianchini, PhD, National Research Council, Italy
Master Degree in Electronic Engineering and PhD in “Automation, Robotics and Bio-engineering” at Pisa University (Italy). Certificate in Technology Entrepreneurship at Leavey School of Business, Santa Clara University (CA, USA). Researcher at the Italian National Research Council (CNR), focus on vascular ageing assessment by ultrasound (vice-chair of the COST Action VascAgeNet, 2019-2024) and on software medical device lifecycle. Member of Artery Executive Committee, vice-chair of the European Society of Hypertension Large Arteries working group. Co-founder of Quipu, spinoff company of CNR and Pisa University, developing software medical device for ultrasound imaging.
Christopher C. Mayer, PhD, AIT Austrian Institute of Technology, Austria Dr. Christopher C. Mayer is Senior Scientist and Project Manager at AIT, he holds a PhD in technical mathematics and is a researcher at AIT since 2009. He has years of experience in biosignal analysis, mathematical modelling, and medical statistics. He has yearlong experience from international and National research projects (including H2020) in various roles (e.g., coordinator, WP leader, task leader, participant, etc.) and was chair of the COST Action VascAgeNet. He is co-inventor of the patent partly used in the ARCSolver algorithms. https://publications.ait.ac.at/en/persons/christopher.mayer
Artrey Reserach is calling for submissions to our Collection on VascAgeNet for translation to practice: mind the gaps and follow the trend.
Translation into practice of vascular ageing assessment was the focus of the COST Action VascAgeNet. Translational science aims to implement translation from basic/preclinical science to human studies and then to transfer new approaches into clinical decision making. Key drivers of this process are technological innovation, (pre-)clinical research and studies, knowledge exchange and these are the main topics of the newborn Artery working groups. Reliable technology is needed for good quality human studies and, when satisfying regulatory and industry requirements, it can facilitate translation to practice; innovation can be derived by and/or it can improve basic/preclinical science’s implementation, and basic/preclinical science can support the direction of clinical trials. Knowledge exchange, supported by clinical evidence, is crucial for dissemination, osmosis among different stakeholders, development of collective intelligence and strategies facilitating translation into the clinical decision making.
The purpose of this special issue is to publish high-quality research papers as well as review articles addressing gaps and trends in the translational process of vascular ageing assessment.
Image credit: vascagenet.eu
There are currently no articles in this collection.
Articles for this Collection should be submitted via our submission system, Snapp. Please, select the appropriate Collection title “VascAgeNet for translation to practice: mind the gaps and follow the trends " under the “Details” tab during the submission stage.
Articles will undergo the journal’s standard peer-review process and are subject to all the journal’s standard policies. Articles will be added to the Collection as they are published.
The Editors have no competing interests with the submissions which they handle through the peer-review process. The peer-review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.